Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SclerFIX-IP in Symptomatic STT Osteoarthritis
NCT06038331Phase 2Active, not recruiting
- Sponsor
- TBF Génie Tissulaire
- Start
- May 2024
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in osteoarthritis (OA), sponsored by TBF Génie Tissulaire. Primary endpoint: Decrease of the symptomatology related to the STT OA at 12 months. Started May 2024; status: active, not recruiting.
02
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06038331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06038331.